ADA Scientific Sessions 2026 Abstract·6 JunThe Impact of Lipid-Modifying Therapy (LMT) on 30-Year Non-HDL Cholesterol and Cardiovascular Disease (CVD) Is Similar by Sex in Type 1 Diabetes (T1D)Study in peoplePopulationsPaper
ADA Scientific Sessions 2026 Abstract·6 JunAge at Menopause Modifies the Effect of Clinical Risk Factors on Coronary Artery Disease (CAD) Incidence in Women with Type 1 Diabetes (T1D)Study in peoplePopulationsPaper
ADA Scientific Sessions 2026 Abstract·5 JunRisk Factors for 30-Year Incidence of Distal Symmetric Polyneuropathy (DSP) by Glycemic Exposure Trajectories in Type 1 Diabetes (T1D)Study in peoplePopulationsPaper
ADA Scientific Sessions 2025 Abstract·13 JunWeight-Adjusted Insulin Dose Is Positively Associated with Estimated GFR (eGFR) in Type 1 DiabetesStudy in peoplePopulationsPaper
ADA Scientific Sessions 2025 Abstract·13 JunRisk Factors Differ by Sex for 30-Year Overt Nephropathy (ON) Incidence But Not for Proliferative Diabetic Retinopathy (PDR) in Type 1 Diabetes (T1D)Study in peoplePopulationsPaper